Company intelligence / Profile preview

Monsanto

St. Louis / Creve Coeur / Chesterfield, Missouri, United Statesmonsantotechnology.com ↗
Ownership
Private
Employees
~20000
Development stage
Commercial
01

Overview

Monsanto was a global leader in genetically engineered seeds and glyphosate-based herbicides. It pioneered commercial GMOs such as Roundup Ready soybeans and corn. The company’s products were widely adopted but also controversial due to environmental and health concerns. At the time of its acquisition by Bayer in June 2018 for $63 billion, Monsanto had a broad commercial portfolio but faced significant litigation over alleged health effects of its products like Roundup.

Therapeutic areas
OtherEndocrinologyRheumatology
Modalities
Genetically modified crops (Biologic)Small molecule herbicides (Small molecule)Synthetic hormones (Small molecule/Protein)Pharmaceuticals
Industry
Agriculture & AgTech
02

Drug pipeline

2 assets

glyphosate

Commercial
Indications
Herbicide

1 more asset in the full pipeline.

Request access →
03

Partnerships

BASF (divestiture partner during merger)various academic collaborations on GMO research

Beyond the preview

Go deeper on Monsanto.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monsanto.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call